Rhox1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Rhox1, a transcription factor that is part of the Rhox (Reproductive Homeobox) gene family. Rhox1 plays a key role in regulating gene expression, particularly in reproductive tissues and developmental processes. Like other homeobox genes, Rhox1 contains a conserved DNA-binding domain, which allows it to interact with specific DNA sequences and control the transcription of genes responsible for processes such as cellular differentiation, growth, and reproductive system development. Inhibitors of Rhox1 typically function by binding to the protein's DNA-binding domain or other critical regions necessary for its activity, thereby blocking its ability to regulate gene expression and preventing it from executing its role in transcriptional regulation.
The inhibition of Rhox1 leads to changes in the gene expression programs that are under its control, especially in tissues where it plays a prominent role, such as reproductive organs. By preventing Rhox1 from binding to its target genes, these inhibitors interfere with the transcriptional networks that coordinate important developmental and cellular processes. Researchers use Rhox1 inhibitors to explore the specific contributions of this transcription factor to broader gene regulatory networks, offering insights into how Rhox1 interacts with other transcription factors and regulatory elements to modulate biological pathways. In addition, these inhibitors provide a useful tool for investigating the functional diversity and specialization of the Rhox gene family, shedding light on the evolutionary conservation and variation of homeobox genes. By examining the inhibition of Rhox1, researchers can gain a deeper understanding of the molecular mechanisms that regulate gene expression during critical phases of development, particularly within reproductive systems, and how these processes have evolved across different species.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit the transcription of multiple genes, potentially reducing Rhox1 expression among other targets. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound causes DNA demethylation, potentially altering gene expression patterns, possibly including Rhox1. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 inhibits BET bromodomains, which could affect the expression of genes regulated by these epigenetic readers, potentially including Rhox1. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and inhibits transcription of GC-rich promoter regions, which might impact Rhox1 expression if its promoter is GC-rich. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This molecule intercalates into DNA, inhibiting transcription initiation and elongation, potentially affecting Rhox1 expression non-selectively. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which is essential for mRNA synthesis, and could decrease Rhox1 expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin acts as an adenosine analog that interrupts RNA chain elongation, potentially reducing the expression of genes like Rhox1. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA polymerase II phosphorylation, which could lead to reduced transcription of Rhox1. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts HIF-1 function, which may indirectly affect the expression of various genes. | ||||||
Canertinib | 267243-28-7 | sc-207397 | 10 mg | $260.00 | 3 | |
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription, potentially impacting genes under this pathway's control, including possibly Rhox1. | ||||||